MIL-OSI USA: NIH-funded researchers reverse congenital blindness in mice
Source: US Department of Health and Human Services – 2 News Release Wednesday, August 15, 2018 New technique generates rod photoreceptors that integrate into the retina and brain. Researchers funded by the National Eye Institute (NEI) have reversed congenital blindness in mice by changing supportive cells in the retina called Müller glia into rod photoreceptors. […]
Read More →MIL-OSI USA: Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new resource guide to support responsible opioid prescribing for pain management in animals
Source: US Department of Health and Human Services – 3 As FDA Commissioner, addressing the opioid epidemic and the misuse and abuse of these drugs remains one of my highest priorities. As we look at tackling the opioid crisis, it’s important that we take a close look at all the access points where these powerful […]
Read More →MIL-OSI USA: Rosenberg, NIH-supported researchers to receive 2018 Albany Prize
Source: US Department of Health and Human Services – 2 News Release Wednesday, August 15, 2018 Steven A. Rosenberg, M.D., Ph.D., of the Center for Cancer Research (CCR) at the National Cancer Institute (NCI), has been named a recipient of the 2018 Albany Medical Center Prize in Medicine and Biomedical Research for his leading role […]
Read More →MIL-OSI USA: NIH study shows how MERS coronavirus evolves to infect different species
Source: US Department of Health and Human Services – 2 Media Advisory Tuesday, August 14, 2018 What In the past 15 years, two outbreaks of severe respiratory disease were caused by coronaviruses transmitted from animals to humans. In 2003, SARS-CoV (severe acute respiratory syndrome coronavirus) spread from civets to infect more than 8,000 people, leading […]
Read More →MIL-OSI USA: Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer
Source: US Department of Health and Human Services – 2 News Release Tuesday, August 14, 2018 An interim analysis of data from a randomized clinical trial of patients with human papillomavirus (HPV)-positive oropharyngeal cancer found that treatment with radiation therapy and cetuximab is associated with worse overall and progression-free survival compared to the current standard […]
Read More →MIL-OSI USA: New NIH reference book is one-stop resource for diabetes medical information
Source: US Department of Health and Human Services – 2 News Release Tuesday, August 14, 2018 “Diabetes in America” sheds light on national burden of diabetes. Diabetes affects a body from head to toe. Now there’s a resource that illustrates its effect on both – and all the parts in between. Thanks to research, what […]
Read More →MIL-OSI USA: During HIV infection, antibody can block B cells from fighting pathogens
Source: US Department of Health and Human Services – 2 Media Advisory Monday, August 13, 2018 NIH scientists suspect process aims to curb immune-system hyperactivity. What For the first time, scientists have shown that in certain people living with HIV, a type of antibody called immunoglobulin G3 (IgG3) stops the immune system’s B cells from […]
Read More →MIL-OSI USA: Experts highlight Ebola vaccine progress and suggest next steps
Source: US Department of Health and Human Services – 2 Media Advisory Monday, August 13, 2018 What Despite promising advances, important scientific questions remain unanswered in the effort to develop a safe and effective Ebola vaccine, according to members of an international Ebola research consortium. In a Viewpoint published in The Lancet, the experts review […]
Read More →MIL-OSI USA: FDA approves new treatment for a rare genetic disorder, Fabry disease
Source: US Department of Health and Human Services – 3 The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indicated for adults with Fabry disease who have a genetic mutation determined to be responsive (“amenable”) to treatment with Galafold […]
Read More →MIL-OSI USA: FDA approves new vaginal ring for one year of birth control
Source: US Department of Health and Human Services – 3 The U.S. Food and Drug Administration today approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), which is a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire […]
Read More →